Kenneth S. Shindler

8.5k total citations
101 papers, 3.8k citations indexed

About

Kenneth S. Shindler is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Ophthalmology. According to data from OpenAlex, Kenneth S. Shindler has authored 101 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 33 papers in Pathology and Forensic Medicine and 29 papers in Ophthalmology. Recurrent topics in Kenneth S. Shindler's work include Multiple Sclerosis Research Studies (25 papers), Sirtuins and Resveratrol in Medicine (15 papers) and Retinal Development and Disorders (14 papers). Kenneth S. Shindler is often cited by papers focused on Multiple Sclerosis Research Studies (25 papers), Sirtuins and Resveratrol in Medicine (15 papers) and Retinal Development and Disorders (14 papers). Kenneth S. Shindler collaborates with scholars based in United States, India and United Kingdom. Kenneth S. Shindler's co-authors include Kevin A. Roth, Abdolmohamad Rostami, Mahasweta Dutt, Reas S. Khan, Elvira Ventura, Kimberly Dine, Cecelia B. Latham, Jayasri Das Sarma, Peter J. Elliott and Jean Bennett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kenneth S. Shindler

96 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth S. Shindler United States	32	1.8k	662	630	552	471	101	3.8k
Jonathan H. Lin United States	36	3.5k 2.0×	502 0.8×	119 0.2×	1.1k 1.9×	449 1.0×	106	6.5k
Philipp Albrecht Germany	33	1.1k 0.6×	707 1.1×	1.0k 1.6×	584 1.1×	361 0.8×	162	3.7k
Tailoi Chan‐Ling Australia	45	2.8k 1.6×	2.5k 3.8×	117 0.2×	741 1.3×	555 1.2×	106	6.8k
Takayuki Harada Japan	42	3.5k 1.9×	1.8k 2.7×	259 0.4×	1.4k 2.6×	596 1.3×	197	5.9k
Tsutomu Nakahara Japan	31	2.0k 1.1×	791 1.2×	161 0.3×	459 0.8×	192 0.4×	234	4.3k
Philip A. Barker Canada	30	2.7k 1.5×	171 0.3×	216 0.3×	948 1.7×	1.2k 2.6×	42	4.4k
Simone Di Giovanni Germany	34	2.3k 1.3×	54 0.1×	744 1.2×	1.5k 2.6×	241 0.5×	79	4.1k
Heidi Scrable United States	31	2.3k 1.3×	44 0.1×	351 0.6×	290 0.5×	229 0.5×	51	4.6k
Mohanish Deshmukh United States	40	4.2k 2.3×	78 0.1×	158 0.3×	978 1.8×	625 1.3×	72	5.6k
Wassim Elyaman United States	33	1.2k 0.7×	157 0.2×	308 0.5×	319 0.6×	2.9k 6.1×	66	5.0k

Countries citing papers authored by Kenneth S. Shindler

Since Specialization

Citations

This map shows the geographic impact of Kenneth S. Shindler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth S. Shindler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth S. Shindler more than expected).

Fields of papers citing papers by Kenneth S. Shindler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth S. Shindler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth S. Shindler. The network helps show where Kenneth S. Shindler may publish in the future.

Co-authorship network of co-authors of Kenneth S. Shindler

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth S. Shindler. A scholar is included among the top collaborators of Kenneth S. Shindler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth S. Shindler. Kenneth S. Shindler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camacho, David, Brahim Chaqour, Jon Rossman, et al.. (2025). Neuroprotective effects of SIRT1 in human RGCs derived from iPSCs following oxidative stress induction at early and late stages of differentiation. Experimental Eye Research. 259. 110526–110526.

Khan, Reas S., Kimberly Dine, John G. Geisler, et al.. (2025). Mitochondrial Uncoupler, 2,4-Dinitrophenol, Reduces Spinal Cord Paralysis and Retinal Ganglion Cell Loss in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. Biomolecules. 15(2). 189–189.

Chaqour, Brahim, Reas S. Khan, Puya Aravand, et al.. (2024). Pharmacological Activation and Transgenic Overexpression of SIRT1 Attenuate Traumatic Optic Neuropathy Induced by Blunt Head Impact. Translational Vision Science & Technology. 13(9). 27–27.

Chaqour, Brahim, et al.. (2024). Comparison of Brn3a and RBPMS Labeling to Assess Retinal Ganglion Cell Loss During Aging and in a Model of Optic Neuropathy. Investigative Ophthalmology & Visual Science. 65(4). 19–19. 6 indexed citations

Chaqour, Brahim, David Camacho, Kimberly Dine, et al.. (2024). AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes. Gene Therapy. 31(3-4). 175–186. 5 indexed citations

Khan, Reas S., Benjamin Davis, Kimberly Dine, et al.. (2024). Effects of oral and intranasal resveratrol nanoparticle administration on neurodegeneration and neuronal dysfunction in a model of multiple sclerosis. Acta Ophthalmologica. 102(S279).

Lin, Shuai-Chun, Grant T. Liu, Robert A. Avery, et al.. (2023). Frequency and Etiologies of Visual Disturbance After Cataract Surgery Identified in Neuro-Ophthalmology Clinics. Journal of Neuro-Ophthalmology. 43(3). 359–363. 1 indexed citations

Chaqour, Brahim, et al.. (2022). Repeat Brn3a immunolabeling rescues faded staining and improves detection of retinal ganglion cells. Experimental Eye Research. 226. 109310–109310. 4 indexed citations

Ross, Ahmara G., et al.. (2022). Resolution of COVID-19 induced anosmia following treatment with ST266. SHILAP Revista de lepidopterología. 25. 100475–100475. 2 indexed citations

10.

Saha, Bhaskar, et al.. (2021). CD40L protects against mouse hepatitis virus-induced neuroinflammatory demyelination. PLoS Pathogens. 17(12). e1010059–e1010059. 7 indexed citations

11.

Willett, Keirnan, et al.. (2021). Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells. PLoS ONE. 16(1). e0243862–e0243862. 9 indexed citations

12.

Pistilli, Maxwell, Anita Kohli, Grant T. Liu, et al.. (2020). Utility of Spectral-Domain Optical Coherence Tomography in Differentiating Papilledema From Pseudopapilledema: A Prospective Longitudinal Study. Journal of Neuro-Ophthalmology. 41(4). e509–e515. 10 indexed citations

13.

Dine, Kimberly, Vy Luong, Benjamin Davis, et al.. (2020). Intranasal delivery of resveratrol nanoparticles reduces retinal ganglion cell loss in a model of multiple sclerosis. Investigative Ophthalmology & Visual Science. 61(7). 2476–2476. 3 indexed citations

14.

Khan, Reas S., Ahmara G. Ross, Keirnan Willett, et al.. (2020). Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis. Neurotherapeutics. 18(1). 448–459. 9 indexed citations

15.

Mallery, Robert M., John Woo, Karen L. Salzman, et al.. (2019). Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without Papilledema. Journal of Neuro-Ophthalmology. 39(3). 299–307. 47 indexed citations

16.

Khan, Reas S., Kimberly Dine, John G. Geisler, & Kenneth S. Shindler. (2017). Mitochondrial Uncoupler Prodrug of 2,4‐Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis. Oxidative Medicine and Cellular Longevity. 2017(1). 7180632–7180632. 35 indexed citations

17.

Addya, Sankar, Reas S. Khan, Lawrence C. Kenyon, et al.. (2014). Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses. PLoS ONE. 9(10). e111351–e111351. 16 indexed citations

18.

Khan, Reas S., Yong Chen, Ying Song, et al.. (2013). Dexras1 Mediates Retinal Ganglion Cell Loss Induced by NMDA Excitotoxicity. Investigative Ophthalmology & Visual Science. 54(15). 1414–1414. 1 indexed citations

19.

Ashtari, Manzar, Laura Cyckowski, Justin F. Monroe, et al.. (2011). The human visual cortex responds to gene therapy–mediated recovery of retinal function. Journal of Clinical Investigation. 121(6). 2160–2168. 107 indexed citations

20.

Shindler, Kenneth S., et al.. (2008). Oral SIRT1 Activators Are Neuroprotective for Retinal Ganglion Cells in Experimental Optic Neuritis. Investigative Ophthalmology & Visual Science. 49(13). 3240–3240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact